89 related articles for article (PubMed ID: 12541248)
1. Quantification of renal perfusion using an intravascular contrast agent (part 1): results in a canine model.
Aumann S; Schoenberg SO; Just A; Briley-Saebo K; Bjørnerud A; Bock M; Brix G
Magn Reson Med; 2003 Feb; 49(2):276-87. PubMed ID: 12541248
[TBL] [Abstract][Full Text] [Related]
2. Quantification of renal perfusion abnormalities using an intravascular contrast agent (part 2): results in animals and humans with renal artery stenosis.
Schoenberg SO; Aumann S; Just A; Bock M; Knopp MV; Johansson LO; Ahlstrom H
Magn Reson Med; 2003 Feb; 49(2):288-98. PubMed ID: 12541249
[TBL] [Abstract][Full Text] [Related]
3. Quantitative renal cortical perfusion in human subjects with magnetic resonance imaging using iron-oxide nanoparticles: influence of T1 shortening.
Morell A; Ahlstrom H; Schoenberg SO; Abildgaard A; Bock M; Bjørnerud A
Acta Radiol; 2008 Oct; 49(8):955-62. PubMed ID: 18615336
[TBL] [Abstract][Full Text] [Related]
4. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent.
Lüdemann L; Nafz B; Elsner F; Grosse-Siestrup C; Meissler M; Kaufels N; Rehbein H; Persson PB; Michaely HJ; Lengsfeld P; Voth M; Gutberlet M
Invest Radiol; 2009 Mar; 44(3):125-34. PubMed ID: 19151609
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a new ultrasmall superparamagnetic iron oxide contrast agent Clariscan, (NC100150) for MRI of renal perfusion: experimental study in an animal model.
Bachmann R; Conrad R; Kreft B; Luzar O; Block W; Flacke S; Pauleit D; Träber F; Gieseke J; Saebo K; Schild H
J Magn Reson Imaging; 2002 Aug; 16(2):190-5. PubMed ID: 12203767
[TBL] [Abstract][Full Text] [Related]
6. [Myocardial microcirculation in humans--new approaches using MRI].
Wacker CM; Bauer WR
Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
[TBL] [Abstract][Full Text] [Related]
7. Assessment of myocardial blood volume and water exchange: theoretical considerations and in vivo results.
Bjørnerud A; Bjerner T; Johansson LO; Ahlström HK
Magn Reson Med; 2003 May; 49(5):828-37. PubMed ID: 12704765
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility contrast magnetic resonance imaging determination of fractional tumor blood volume: a noninvasive imaging biomarker of response to the vascular disrupting agent ZD6126.
Robinson SP; Howe FA; Griffiths JR; Ryan AJ; Waterton JC
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):872-9. PubMed ID: 17889267
[TBL] [Abstract][Full Text] [Related]
9. MR image-guided endovascular procedures with the ultrasmall superparamagnetic iron oxide SH U 555 C as an intravascular contrast agent: study in pigs.
Wacker FK; Reither K; Ebert W; Wendt M; Lewin JS; Wolf KJ
Radiology; 2003 Feb; 226(2):459-64. PubMed ID: 12563140
[TBL] [Abstract][Full Text] [Related]
10. First-pass myocardial perfusion MR imaging with outer-volume suppression and the intravascular contrast agent NC100150 injection: preliminary results in eight patients.
Bjerner T; Johansson L; Ericsson A; Wikström G; Hemmingsson A; Ahlström H
Radiology; 2001 Dec; 221(3):822-6. PubMed ID: 11719685
[TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic tumor treatment: early noninvasive monitoring with USPIO-enhanced MR imaging in mice.
Persigehl T; Bieker R; Matuszewski L; Wall A; Kessler T; Kooijman H; Meier N; Ebert W; Berdel WE; Heindel W; Mesters RM; Bremer C
Radiology; 2007 Aug; 244(2):449-56. PubMed ID: 17562810
[TBL] [Abstract][Full Text] [Related]
12. Quantifying the blood oxygenation level dependent effect in cerebral blood volume-weighted functional MRI at 9.4T.
Lu H; Scholl CA; Zuo Y; Stein EA; Yang Y
Magn Reson Med; 2007 Sep; 58(3):616-21. PubMed ID: 17763339
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive measurement of absolute renal perfusion by contrast medium-enhanced magnetic resonance imaging.
Montet X; Ivancevic MK; Belenger J; Jorge-Costa M; Pochon S; Pechère A; Terrier F; Vallée JP
Invest Radiol; 2003 Sep; 38(9):584-92. PubMed ID: 12960528
[TBL] [Abstract][Full Text] [Related]
14. [Splenosis: value of MRI with injection of a superparamagnetic contrast agent].
Roussel A; Petit E; Mallet L; Zins M
J Radiol; 2008 Dec; 89(12):1944-6. PubMed ID: 19106854
[No Abstract] [Full Text] [Related]
15. Influence of blood-pool contrast media on MR imaging and flow measurements in the presence of pulmonary arterial stents in swine.
Kuehne T; Saeed M; Moore P; Gleason K; Reddy G; Teitel D; Higgins CB
Radiology; 2002 May; 223(2):439-45. PubMed ID: 11997550
[TBL] [Abstract][Full Text] [Related]
16. Changes in signal-to-noise ratios and contrast-to-noise ratios of hypervascular hepatocellular carcinomas on ferucarbotran-enhanced dynamic MR imaging.
Park Y; Choi D; Kim SH; Kim SH; Kim MJ; Lee J; Lim JH; Lee WJ; Lim HK
Eur J Radiol; 2006 Sep; 59(3):424-31. PubMed ID: 16920312
[TBL] [Abstract][Full Text] [Related]
17. Validation of Perfusion Quantification with 3D Gradient Echo Dynamic Contrast-Enhanced Magnetic Resonance Imaging Using a Blood Pool Contrast Agent in Skeletal Swine Muscle.
Hindel S; Sauerbrey A; Maaß M; Maderwald S; Schlamann M; Lüdemann L
PLoS One; 2015; 10(6):e0128060. PubMed ID: 26061498
[TBL] [Abstract][Full Text] [Related]
18. Assessment of T1 and T2* effects in vivo and ex vivo using iron oxide nanoparticles in steady state--dependence on blood volume and water exchange.
Bjørnerud A; Johansson LO; Briley-Saebø K; Ahlström HK
Magn Reson Med; 2002 Mar; 47(3):461-71. PubMed ID: 11870832
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of experimental atherosclerotic plaque: comparison of two ultrasmall superparamagnetic particles of iron oxide.
Herborn CU; Vogt FM; Lauenstein TC; Dirsch O; Corot C; Robert P; Ruehm SG
J Magn Reson Imaging; 2006 Aug; 24(2):388-93. PubMed ID: 16791857
[TBL] [Abstract][Full Text] [Related]
20. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics.
Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH
Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
